首页> 外文期刊>Journal of affective disorders >A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders
【24h】

A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders

机译:中国中度重度抑郁症患者认知行为疗法,抗抑郁药,其联合用药与标准治疗的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: No study has examined the effect of cognitive-behavioral therapy (CBT) on moderate-severe major depressive disorders (MDD) in China. The objective of this study was to evaluate the effect of CBT, antidepressants alone (MED), combined CBT and antidepressants (COMB) and standard treatment (ST; i.e., receiving psycho-educational intervention and/or medication treatment determined by treating psychiatrists) on depressive symptoms and social functioning in Chinese patients with moderate-severe MDD. Method: A total of 180 patients diagnosed with MDD according to ICD-10 were randomly allocated to one of the four treatment regimens for a period of 6 months. Depressive symptoms were measured using the Hamilton Rating Scale for Depression (HAMD) and the Quick Inventory of Depressive Symptomatology-Self-Report (C-OJDS-SR). Remission threshold was defined as a C-QIDS-SR total score of < 5. Social functioning was evaluated with the Work and Social Adjustment Scale (WSAS). All outcome measures were evaluated at entry, and at 3- and 6-months follow-up.Results: At the 6-months assessment, the remission rates in the whole sample (n=96), the MED, the CBT, the COMB and the ST groups were 54.2%, 48%, 75%, 53.5% and 50%, respectively. Following the treatment periods, there was no significant difference in any of the study outcomes between the four groups. However, the CBT showed the greatest effect in the HAMD total score with the effect size=0.94, whereas the ST has only a moderate effect size in the WSAS total score (effect size=0.47).Conclusions: The findings support the feasibility and effectiveness of CBT as a psychosocial intervention for Chinese patients with moderate-severe MDD. We also found that single treatment using MED or CBT performed equally well as the combined CBT-antidepressant treatment in controlling the remission. The study provided important knowledge to inform the mental health care planning in China.
机译:背景:目前尚无研究探讨认知行为疗法(CBT)对中重度抑郁症(MDD)的影响。这项研究的目的是评估CBT,单独的抗抑郁药(MED),CBT和抗抑郁药联合使用(COMB)和标准治疗(ST;即接受心理教育干预和/或通过治疗精神病医生确定的药物治疗)的效果。中国中重度MDD患者的抑郁症状和社会功能方法:将总共180名根据ICD-10诊断为MDD的患者随机分配至四种治疗方案之一,为期6个月。使用汉密尔顿抑郁量表(HAMD)和抑郁症状自评量表(C-OJDS-SR)测量抑郁症状。缓解阈值定义为C-QIDS-SR总得分<5。使用工作和社会适应量表(WSAS)评价社会功能。在入组时以及在3个月和6个月的随访中评估了所有结果指标。结果:在6个月的评估中,整个样本(n = 96),MED,CBT,COMB的缓解率ST组分别为54.2%,48%,75%,53.5%和50%。在治疗期之后,四组之间的任何研究结果均无显着差异。然而,CBT在HAMD总分中表现出最大的效应,效应大小= 0.94,而ST在WSAS总分中仅具有中等效应大小(效应大小= 0.47)。 CBT作为中重度MDD中国患者的社会心理干预措施。我们还发现,使用MED或CBT进行的单一治疗在控制缓解方面的效果与联合使用CBT-抗抑郁药的效果相同。该研究提供了重要的知识,可为中国的精神卫生保健计划提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号